She received her PhD and MPH from the Johns Hopkins Bloomberg School of Public Health. Her research encompasses HIV and hepatitis C virus among injection drug using populations, with a particular focus on improving access to care and treatment for HIV and hepatitis C. She leads a longitudinal cohort of IDUs in Baltimore, the ALIVE study, as well as several studies in India focused on HIV and hepatitis C.